Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > EADV Congress 2022

EADV Congress 2022

September 7-10, 2022 | Milan & Online

We are pleased to share that our team will be attending EADV Congress 2022 in Milan this September. EADV Congress is an outstanding educational and learning experience for dermatologists and venereologists world-wide, and our team will be pleased to join it alongside our partner Legit.Health.

Alira Health and Legit.Health will be attending EADV Congress 2022 following the roll-out of the unique next generation technology solution for dermatology DCT, RWE and DTx. This joint solution is designed to automate the verification of inclusion criteria, automate participant monitoring and clinical endpoint acquisition and recruitment, and increase the diversity of participants. Learn more about the solution from the partnership announcement.

Events
Category:
Decentralized Clinical Trials Digital Therapeutics Real-World Evidence (RWE)
Published on:
September 6, 2022
Our delegates
Andrea Mantovani

Andrea Mantovani

 Vice President, Global Market Access & Pricing, Alira Health
Kumara Prasad Palanivel

Dr. Kumara Prasad Palanivel

 Director, Digital Medical Strategy, Alira Health

Would you like to meet at EADV and learn more about our unique platform for dermatology DCT, RWE and DTx?

Contact us to set up a meeting

Related news

Events April 22, 2025
MEET2WIN 2025
Discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.
Clinical EU Oncology Real-World Evidence (RWE) Transaction Advisory
Uncategorized April 8, 2025
Alira Health et Euris Health Cloud collaborent avec Gustave Roussy pour le développement de la plateforme digitale d’Interception
Alira Health est fière de collaborer en tant que partenaire commercial au développement numérique du projet Interception, une initiative pionnière dans le domaine de la prévention(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News February 27, 2025
Alira Health Oversees the Digital Development of Gustave Roussy’s Project Interception to Advance Cancer Prevention
Alira Health, a global healthcare advisory and technology company, is proud to collaborate as a commercial partner with the digital development of Project Interception, a pioneering(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
News January 14, 2025
Alira Health Launches SpherePX™, a Next-Generation Technology Platform to Advance Real-World Evidence
Alira Health announces the global launch of its innovative technology platform SpherePX, designed to drive real-world evidence (RWE) collection and elevate patient engagement and retention.(...)
Healthcare Technology Patient Centricity Patient-Enabled Innovation Real-World Evidence (RWE)
Articles July 4, 2024
Navigating Market Access for Rare Diseases: The Potential of Real-World Evidence
Our experts answer common questions about the strategic need for real-world evidence to drive market access for rare diseases.
Market Access Rare Disease Real-World Evidence (RWE)
Articles June 6, 2024
The Role of Real-World Data in the Development of Lupus Solutions
This article explores the benefits of RWD in lupus, the value of leveraging RWD throughout the lupus product lifecycle, and the RWD sources available in this indication.
Lupus Real-World Evidence (RWE)
News May 6, 2024
Alira Health’s CDD Advises TVM Capital Healthcare Investment in neurocare Group AG
We are pleased to have been a Commercial Due Diligence advisor for an investment by TVM Capital Healthcare into neurocare group AG. The Munich-based leader in personalized mental health(...)
CDD Digital Therapeutics
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.